Chronic pain: Second, do no harm

American Journal of Physical Medicine and Rehabilitation

Volumn 87, Issue 1, 2008, Pages 78-83

  Barbuto, John P ^a,d   White Jr , George L ^b   Porucznik, Christina A ^b   Holmes, Edward B ^a,c  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c State of Utah   (United States)

^d NONE   (United States)

Author keywords

Abuse; Biopsychosocial; Evaluation; Function; Pain; Pathophysiology

Indexed keywords

NARCOTIC ANALGESIC AGENT;

CHRONIC PAIN; COGNITIVE DEFECT; DEPRESSION; DISEASE SEVERITY; ELECTRODIAGNOSIS; HOSPICE CARE; HUMAN; MUSCLE STRAIN; NOCICEPTION; NUCLEAR MAGNETIC RESONANCE IMAGING; PALLIATIVE THERAPY; PRACTICE GUIDELINE; PRESCRIPTION; REVIEW; SOCIAL PSYCHOLOGY; SOCIAL STATUS; SOMATIZATION; SPRAIN; TREATMENT OUTCOME;

ADAPTATION, PSYCHOLOGICAL; CHRONIC DISEASE; HUMANS; PAIN; PAIN MEASUREMENT; PSYCHOLOGY; QUALITY OF LIFE; SUBSTANCE-RELATED DISORDERS;

EID: 37549039032     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/PHM.0b013e31815e87b1     Document Type: Review

References (29)

1. World Health Organization: Palliative Cancer Care: Policy Statement Based on the Recommendations of a WHO Consultation. Geneva, World Health Organization, 1989
2. Schechter NL: The undertreatment of pain in children: an overview. Pediatr Clin North Am 1989;36:94
3. Crosse M: GAO-04-110: OxyContin Abuse and Diversion and Efforts to Address the Problem. Washington, DC, United States General Accounting Office, 2003
4. Glajchen M: Chronic pain: treatment barriers and strategies for clinical practice. J Am Board Fam Pract 2001;14:211-8
5. National Institutes of Health: NIH Guide: Prescription Drug Abuse. Washington, DC, Department of Health and Human Services, 2004
6. National Institute on Drug Abuse: NIDA InfoFacts: Prescription Pain and Other Medications. Available at: http://www.nida.nih.gov/infofacts/ PainMed.html. Accessed March 11, 2006
7. Meadows M: Prescription drug use and abuse. Available at: http://www.fda.gov/fdac/features/2001/501_drug.html. Accessed March 11, 200
8. National Drug Intelligence Center: Pharmaceuticals. Available at: http://www.usdoj.gov/ndic/pubs11/18862/pharm.htm#Top. Accessed March 11, 2006
9. Barsky AJ, Orav EJ, Bates DW: Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry 2005;62:903-10
10. Hansen GR, Streltzer J: The psychology of pain. Emerg Med Clin North Am 2005;23:339-48
11. Records S: "First, do no harm" not in the Hippocratic oath. Available at: http://www.geocities.com/everwild7/noharm.html. Accessed October 18, 2005
12. Cicero TJ, Incardi JA, Munoz A: Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002-2004. J Pain 2005;6:662-72
13. Smith MY, Woody G: Non-medical use and abuse of scheduled medications prescribed for pain, pain-related symptoms, and psychiatric disorders: patterns, user characteristics, and management options, Curr Psychiatry Rep 2005;7:337-43
14. Woolf CJ, Hashmi M: Use and abuse of opioid analgesics: potential methods to prevent and deter non-medical consumption of prescription opioids. Curr Opin Investig Drugs 2004;5:61-6
15. Inciardi JA, Surratt HL, Kurtz SP, Burke JJ: The diversion of prescription drugs by health care workers in Cincinnati, Ohio. Subst Use Misuse 2006;41:255-64
16. Colvi R: Prescription Drug Abuse: The Hidden Epidemic: A Guide to Coping and Understanding. Omaha, Addicus Books, 1995
17. Czechowicz D: Prescription drug abuse. Available at: http://grants.nih. gov/grants/guide/pa-files/PA-04-110.html. Accessed November 26, 2005
18. Balevi B: The dentist and prescription drug abuse. J Can Dent Assoc 1996;62:56-60
19. Sajan A, Corneil T, Grzybowski S: The street value of prescription drugs. CMAJ 1998;159:139-42
20. Community Epidemiology Work Group: Epidemiologic Trends in Drug Abuse. Bethesda, National Institutes of Health, 2005
21. Kraman P: Rx for prescription drug abuse. State News (Council of State Governments) May 2004:13-5
22. Engel GL: The need for a new medical model: a challenge for biomedicine. Science 1977;196:129-36
23. Guides to the Evaluation of Permanent Impairment, ed 3, revised. Chicago, American Medical Association, 1990
24. World Health Organization: National Cancer Control Programs: Policies and Managerial Guidelines. Geneva, World Health Organization, 2002
25. Little CA, Williams SE, Puzanovova M, Rudzinski ER, Walker LS: Multiple somatic symptoms linked to positive screen for depression in pediatric patients with chronic abdominal pain. J Pediatr Gastroneterol Nutr 2007;44:58-62
26. Lecrubier Y: Physical components of depression and psychomotor retardation. J Clin Psychiatry 2006;67(suppl 6):23-6
27. Kroenke K, Rosmalen JG: Symptoms, syndromes and the value of psychiatric diagnostics in patients who have functional somatic disorders Med Clin North Am 2006;90:603-26
28. Peveler R, Katona C, Wessely S, Dowrick C: Painful symptoms in depression: under-recognized and under-treated? Br J Psychiatry 2006;188:202-3
29. Greden JF: Physical symptoms of depression: unmet needs J Clin Psychiatry 2003;64(suppl 7):5-11